QualityStocksNewsBreaks – Trxade Group Inc. (NASDAQ: MEDS) Offers ‘Radical Price Transparency’ to Maximize Savings, Lower Costs of Pharmaceuticals
Trxade Group (NASDAQ: MEDS), an integrated drug-procurement, delivery and health-care platform, has achieved a growing distinction and web-based presence, offering transparency in pharmaceutical purchasing. The company’s flagship Bonum+ platform provides subscribers with access to drug prices and supply availability, enabling them to make informed product ordering decisions. A recent article discussing this quotes Trxade Group founder, chairman and CEO Suren Ajjarapu, who states, “Our platform lets these independents know that they’re receiving a fair price from competing suppliers on fair payment terms and often with next day delivery. We believe this radical price transparency, economy of scale and competition amongst…